Results 31 to 40 of about 74,737 (254)
Guillain-Barré syndrome: expanding the concept of molecular mimicry.
Trends in immunology, 2022 Guillain-Barré syndrome (GBS) is a rapidly progressive, monophasic, and potentially devastating immune-mediated neuropathy in humans. Preceding infections trigger the production of cross-reactive antibodies against gangliosides concentrated in human ...
J. Laman +3 more
semanticscholar +1 more source
Guillain–Barré syndrome with unilateral peripheral facial and bulbar palsy in a child: A case report
SAGE Open Medical Case Reports, 2019 Guillain–Barré syndrome is characterized by progressive motor weakness, sensory changes, dysautonomia, and areflexia. Cranial nerve palsies are frequent in Guillain–Barré syndrome.
Kamal Sharma +4 more
doaj +1 more source
A rare clinical presentation of Ebstein-Barr virus
Brazilian Journal of Infectious Diseases, 2010 In this letter we report a case of Guillain-Barré syndrome associated with infectious mononucleosis. A 20-year-old woman presented to our hospital with weakness of legs and arms.
Çagatay Öncel
doaj +1 more source
Descending paralysis as an atypical presentation of Guillain–Barré Syndrome
SAGE Open Medical Case Reports, 2021 We herein report a case of a 55-year-old man with an unusual case of Guillain–Barré Syndrome. Its presentation is usually a progression of symmetric muscle weakness that is ascending from the lower extremities making its way more proximal and accompanied
Ala Mustafa +2 more
doaj +1 more source
Guillain-Barré Syndrome associated with SARS-CoV-2 infection
IDCases, 2020 We present a case of Guillain- Barré Syndrome (GBS) in a patient with confirmed COVID-19 infection. GBS in commonly encountered after an antecedent trigger, most commonly an infection. To date, only one case of GBS associated with this infection has been
A. Virani +7 more
semanticscholar +1 more source
Neonatal Fc receptor promoter gene polymorphism does not predict pharmacokinetics of IVIg or the clinical course of GBS [PDF]
, 2016 Treatment of Guillain-Barré syndrome with a standard course of high-dose intravenous immunoglobulin (IVIg) results in a variable clinical recovery which is associated with changes in serum IgG levels after treatment. The neonatal Fc-receptor protects IgG
Doorn, P.A. (Pieter) van +6 more
core +1 more source
Frontiers in Cellular and Infection Microbiology, 2023 Psittacosis and Guillain-Barré syndrome are both rare clinical diseases with low incidence, and their combination has rarely been reported. Here, we report a case of Chlamydia psittaci pneumonia combined with Guillain-Barré syndrome.
Changquan Fang +5 more
doaj +1 more source
COVID‐19–associated Guillain‐Barré syndrome: The early pandemic experience
Muscle and Nerve, 2020 Guillain‐Barré syndrome (GBS) is an inflammatory polyradiculoneuropathy associated with numerous viral infections. Recently, there have been many case reports describing the association between coronavirus disease‐2019 (COVID‐19) and GBS, but much ...
J. Caress +6 more
semanticscholar +1 more source
Cost-effectiveness of a potential Zika vaccine candidate: a case study for Colombia [PDF]
, 2018 Background: A number of Zika vaccine platforms are currently being investigated, some of which have entered clinical trials. We sought to evaluate the cost-effectiveness of a potential Zika vaccine candidate under the WHO Vaccine Target Product Profile ...
Moghadas, Seyed +2 more
core +2 more sources
Guillain–Barre syndrome after myocardial infarction: a case report and literature review
BMC Cardiovascular Disorders, 2023 Background Guillain–Barre syndrome after myocardial infarction occurs infrequently, and its occurrence following percutaneous coronary intervention is extremely rare.
Pu-yuan Wen +5 more
doaj +1 more source